Transforming Biopharma

Data as an asset: From real-world evidence to actionable insights with Dr. Aarti Shah

September 26, 2022 ZS Season 1 Episode 3
Data as an asset: From real-world evidence to actionable insights with Dr. Aarti Shah
Transforming Biopharma
More Info
Transforming Biopharma
Data as an asset: From real-world evidence to actionable insights with Dr. Aarti Shah
Sep 26, 2022 Season 1 Episode 3
ZS

Dr. Aarti Shah, former senior vice president and chief information and digital officer at Eli Lilly & Company, knows pharma and technology inside and out. At Eli Lilly, she led an enterprise-wide global organization with responsibilities for information technology, information security, advanced analytics, data science and digital health. Dr. Shah has been named a woman of influence by the Indianapolis Business Journal and was also named one of the fierce women in biopharma by Fierce Pharma. 

In this episode, Dr. Shah and Maria Whitman talk about how real-world evidence is driving faster industry innovations that have great potential to improve patient outcomes. 

Show Notes

Dr. Aarti Shah, former senior vice president and chief information and digital officer at Eli Lilly & Company, knows pharma and technology inside and out. At Eli Lilly, she led an enterprise-wide global organization with responsibilities for information technology, information security, advanced analytics, data science and digital health. Dr. Shah has been named a woman of influence by the Indianapolis Business Journal and was also named one of the fierce women in biopharma by Fierce Pharma. 

In this episode, Dr. Shah and Maria Whitman talk about how real-world evidence is driving faster industry innovations that have great potential to improve patient outcomes.